Trials / Completed
CompletedNCT06941883
Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals
A Study of Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to compare the safety and outcome of ultrasound (US)- guided botulinum toxin (BoNT) injection and anatomically guided injection in muscle spasticity of different causes in adults.
Detailed description
One of the major complications of neurological diseases is spasticity which is defined as an increased velocity-dependent muscle tone. A large volume of clinical data has demonstrated the efficacy and safety of botulinum toxin type A (BoNT-A) products for treating conditions such as spasticity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin injection under anatomical landmark | Patients received botulinum toxin injections under the anatomical landmark. |
| DRUG | Ultrasound-guided botulinum toxin injection | Patients received ultrasound-guided botulinum toxin injection |
Timeline
- Start date
- 2023-07-16
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2025-04-24
- Last updated
- 2025-04-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06941883. Inclusion in this directory is not an endorsement.